Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1403864-74-3 | MDL No. : | MFCD26406403 |
Formula : | C8H16ClNO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | MHKATGTXYBTTMS-UHFFFAOYSA-N |
M.W : | 177.67 | Pubchem ID : | 71627037 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 1.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 47.25 |
TPSA : | 46.25 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.77 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 0.86 |
Log Po/w (WLOGP) : | 1.58 |
Log Po/w (MLOGP) : | 1.22 |
Log Po/w (SILICOS-IT) : | 1.27 |
Consensus Log Po/w : | 0.99 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.48 |
Solubility : | 5.84 mg/ml ; 0.0329 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.41 |
Solubility : | 6.84 mg/ml ; 0.0385 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.11 |
Solubility : | 13.6 mg/ml ; 0.0767 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.97 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | Stage #1: With hydrogen In methanol at 50℃; Stage #2: With hydrogenchloride In methanol at 20℃; for 2 h; |
To a solution of benzyl 4-hydroxybicyclo[2.2.2]octan-l-ylcarbamate (14.8 g, 53 mmol) in methanol (200 mL) was added palladium on charcoal (0.5 g, 10percent). The reaction mixture was stirred at 50 °C under hydrogen atmosphere (50 Psi) overnight and filtered through celite. The filtrate was concentrated and the residue was added to hydrochloric acid in methanol (10percent, 50 mL). The mixture was stirred for 2 h at room temperature. Then the mixture was concentrated again and THF (20 mL) was added. The mixture was stirred at room temperature for 1 h and the precipitate was collected and dried to give the title product (6.7 g, 36 mmol, 70 percent yield).1H NMR (DMSO-< 5) δ 8.00 (s, 3H), 4.48 (br s,lH) ,1.76- 1.80 (m, 6H), 1.58-1.61 (m, 6H). MS (ESI) m/z 142.1 [M+1] +. |
[ 62075-23-4 ]
trans-4-Aminoadamantan-1-ol hydrochloride
Similarity: 0.92
[ 62058-03-1 ]
Rel-(1R,3S,4R)-4-aminoadamantan-1-ol
Similarity: 0.88
[ 76445-65-3 ]
4-Aminocyclohexanol hydrochloride
Similarity: 0.83
[ 56239-26-0 ]
cis-4-Aminocyclohexanol hydrochloride
Similarity: 0.83
[ 62075-23-4 ]
trans-4-Aminoadamantan-1-ol hydrochloride
Similarity: 0.92
[ 62058-03-1 ]
Rel-(1R,3S,4R)-4-aminoadamantan-1-ol
Similarity: 0.88
[ 76445-65-3 ]
4-Aminocyclohexanol hydrochloride
Similarity: 0.83
[ 56239-26-0 ]
cis-4-Aminocyclohexanol hydrochloride
Similarity: 0.83
[ 62075-23-4 ]
trans-4-Aminoadamantan-1-ol hydrochloride
Similarity: 0.92
[ 62058-03-1 ]
Rel-(1R,3S,4R)-4-aminoadamantan-1-ol
Similarity: 0.88
[ 76445-65-3 ]
4-Aminocyclohexanol hydrochloride
Similarity: 0.83
[ 56239-26-0 ]
cis-4-Aminocyclohexanol hydrochloride
Similarity: 0.83